Skip to main content

Table 5 Clinical decision making in anticoagulation

From: Education and practice gaps on atrial fibrillation and anticoagulation: a survey of cardiovascular nurses

Statement

SD

D

N

A

SA

Rating Count

n (%)

n (%)

n (%)

n (%)

n (%)

The risk of stroke versus the risk of bleeding is clearly articulated to patients when commencing anticoagulation for stroke prevention in AF

3 (6)

9 (17)

14 (26)

24 (44)

4 (7)

54

I am unsure whether to advocate for thromboprophylaxis or not when involved in team decisions

7 (13)

22 (41)

14 (26)

10 (19)

1 (2)

54

It’s difficult to decide where the benefits of thromboprophylaxis outweigh the risks of hemorrhage

3 (7)

27 (50)

10 (19)

14 (26)

0 (0)

54

I feel I do not know enough about the risk and benefits of different anticoagulants

5 (9)

30 (57)

4 (8)

12 (23)

2 (4)

53

I take time to understand my patients views on the risks and benefits of anticoagulation

0 (0)

7 (13)

10 (19)

31 (58)

6 (11)

54

Generally, my patients are well informed about the risks and benefits of anticoagulation at time of commencement

3 (6)

8 (15)

11 (20)

28 (52)

4 (7)

54

My patients receive comprehensive education about anticoagulation prior to discharge

2 (4)

5 (9)

10 (19)

26 (48)

11 (20)

54

I use the CHADS2 or CHA2DS2-VASc scores with patients to help risk stratify stroke risk in clinical practice

6 (12)

12 (23)

15 (29)

13 (25)

6 (12)

52

I use the HAS-BLED score with patients to help risk stratify bleeding risk in clinical practice

11 (22)

13 (26)

16 (31)

9 (18)

2 (4)

51

I use shared decision making with patients to explain the risks and benefits of anticoagulation for stroke prevention in AF

5 (9)

7 (13)

14 (26)

23 (43)

5 (9)

54